Paper357967
Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (first of three parts).
Dean J and 1 other. N Engl J Med, 1978. Cited by 211 papers, by iCite.
Cite this record
ConductScience Library. Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (first of three parts). Papers, record 357967. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/357967
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (first of three parts).
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anemia, Sickle Cell | Major topic |
| Hemoglobin, Sickle | Major topic |
| Gels | |
| Hemoglobin A | |
| Hemoglobins | |
| Humans | |
| Kinetics | |
| Models, Chemical | |
| Molecular Conformation | |
| Oxygen | |
| Polymers | |
| Temperature |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01932554 | Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis | Background |
Source ClinicalTrials.gov
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 211 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42903520 | Genetics of protein structures. | Hlife | 2026 | https://conductscience.org/library/papers/42903520 | PubMed |
| 41993330 | Decoupling Detection and Classification to Improve Morphological Phenotype Analysis of Sickle Red Blood Cells in Full-Scope Microscopy. | bioRxiv | 2026 | https://conductscience.org/library/papers/41993330 | PubMed |
| 39205400 | Sickle Cell Hemoglobin "Drugged" with Cyclic Peptides Is Aggregation Incompetent. | J Phys Chem B | 2024 | https://conductscience.org/library/papers/39205400 | PubMed |
| 33475200 | Bulk volume susceptibility difference between deoxyhemoglobin and oxyhemoglobin for HbA and HbS: A comparative study. | Magn Reson Med | 2021 | https://conductscience.org/library/papers/33475200 | PubMed |
| 31637552 | Diagnosing sickle cell disease and iron deficiency anemia in human blood by Raman spectroscopy. | Lasers Med Sci | 2020 | https://conductscience.org/library/papers/31637552 | PubMed |
| 31637541 | From fiction to science: clinical potentials and regulatory considerations of gene editing. | Clin Transl Med | 2019 | https://conductscience.org/library/papers/31637541 | PubMed |
| 28270342 | Cholelithiasis and its complications in sickle cell disease in a university hospital. | Rev Bras Hematol Hemoter | 2017 | https://conductscience.org/library/papers/28270342 | PubMed |
| 27437432 | Dynamic deformability of sickle red blood cells in microphysiological flow. | Technology (Singap World Sci) | 2016 | https://conductscience.org/library/papers/27437432 | PubMed |
| 26623213 | Musculoskeletal Manifestations of Sickle Cell Disease: A Review. | Cureus | 2015 | https://conductscience.org/library/papers/26623213 | PubMed |
| 25037561 | Protein carbamylation in kidney disease: pathogenesis and clinical implications. | Am J Kidney Dis | 2014 | https://conductscience.org/library/papers/25037561 | PubMed |
| 23599605 | Skeletal scintigraphy manifestations of hematologic disorders. | Indian J Nucl Med | 2012 | https://conductscience.org/library/papers/23599605 | PubMed |
| 10079113 | In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse. | J Clin Invest | 1999 | https://conductscience.org/library/papers/10079113 | PubMed |
| 8485022 | The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjects. | Br J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8485022 | PubMed |
| 7640143 | Pharmacokinetics and pharmacodynamics of tucaresol, an antisickling agent, in healthy volunteers. | Br J Clin Pharmacol | 1995 | https://conductscience.org/library/papers/7640143 | PubMed |
| 6940165 | Sickle cell hemoglobin fiber structure altered by alpha-chain mutation. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6940165 | PubMed |
| 6933568 | Determination of deoxyhemoglobin S polymer in sickle erythrocytes upon deoxygenation. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6933568 | PubMed |
| 6933482 | Sickle-cell hemoglobin: fall in osmotic pressure upon deoxygenation. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6933482 | PubMed |
| 6752430 | Sickle cell trait: an update. | J Natl Med Assoc | 1982 | https://conductscience.org/library/papers/6752430 | PubMed |
| 6690472 | Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6690472 | PubMed |
| 6511979 | Sickle cell disease in Britain. | J Clin Pathol | 1984 | https://conductscience.org/library/papers/6511979 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/357967
GET https://conductscience.org/api/papers/v1/357967/cited_by?page=2